On behalf of the Organizing Committee, I am delighted to invite all of you to attend the APASL STC 2022 on Critical Care in Hepatology: ACLF, which is going to be held on 16-18 Sep 2022 in Wuhan, China.

In 2009, the Asian Pacific Association for the Study of the Liver (APASL) provided the first consensus recommendations on ACLF, defined as “an acute hepatic insult manifesting as jaundice and coagulopathy, complicated within 4 weeks by ascites and/or encephalopathy”, later updated in 2014. ACLF is a dynamic syndrome associated with organ failure characterized by a short-term high mortality.

It’s time for us to bring the scientists, surgeons, hepatologists, intensive care unit teams and other professionals together again to review the medical discovery and technology advancement in the past decade. Ultimately to provide better patient care by the joint effort of the enhanced multi-disciplinary team work.

Although vaccines are available to many, the various strains of COVID-19 still seem to bring uncertainty in travel and gatherings. The pandemic may stop us from attending

conferences and meetings physically, but it cannot stop us from exchanging research

findings and saving lives.

Stay tuned for more details from Wuhan, China!